Recombinant Danio rerio Poly (A)-specific ribonuclease PARN (parn), partial

Shipped with Ice Packs
In Stock

Description

Introduction to Recombinant Danio rerio Poly (A)-specific Ribonuclease PARN (parn), partial

Recombinant Danio rerio Poly (A)-specific ribonuclease PARN (parn), partial, is a recombinant protein derived from the zebrafish (Danio rerio) gene encoding Poly (A)-specific ribonuclease (PARN). PARN is an enzyme involved in the degradation of poly(A) tails of messenger RNA (mRNA), which plays a crucial role in regulating mRNA turnover and gene expression . This recombinant form is often used in research to study the functions of PARN in various biological processes.

Gene and Protein Information

  • Gene Names: The gene encoding PARN in zebrafish is known as parn and zgc:56067.

  • Other Names: It is also referred to as Poly(A)-specific ribonuclease PARN or poly(A)-specific ribonuclease (deadenylation nuclease) .

  • Host/Reactivities: The recombinant protein can be expressed in various hosts, including E. coli, yeast, baculovirus, or mammalian cells .

  • Purity: The purity of the recombinant protein is typically greater than or equal to 85% as determined by SDS-PAGE .

Biological Functions of PARN

PARN is primarily known for its role in mRNA degradation by shortening the poly(A) tail, which is crucial for mRNA stability and translation efficiency . Beyond mRNA turnover, PARN has been implicated in the processing of non-coding RNAs, including telomerase RNA and ribosomal RNA (rRNA) . In zebrafish, PARN mutations have been associated with hematopoietic defects and developmental abnormalities, highlighting its importance in developmental biology .

Hematopoiesis and Development

Studies using zebrafish models have shown that PARN plays a critical role in hematopoiesis. Mutations in the parn gene lead to a decrease in mature myeloid cell lineages and hemoglobin levels, while hematopoietic stem cell numbers remain unaffected . This suggests that PARN is essential for the differentiation of hematopoietic stem cells into myeloid and erythroid lineages.

Ribosome Biogenesis

PARN has been identified as a factor involved in the maturation of human 18S ribosomal RNA (rRNA), which is crucial for ribosome biogenesis . It participates in the 3' to 5' trimming of the internal transcribed spacer 1 (ITS1) region of pre-rRNA, a step necessary for the production of mature 40S ribosomal subunits .

Disease Association

Mutations in the PARN gene have been linked to human diseases such as dyskeratosis congenita and pulmonary fibrosis . Dyskeratosis congenita is characterized by bone marrow failure, which can be replicated in zebrafish models by disrupting the parn gene .

Table 1: Key Features of Recombinant Danio rerio PARN

FeatureDescription
Gene Namesparn, zgc:56067
HostsE. coli, yeast, baculovirus, mammalian cells
Purity≥ 85% by SDS-PAGE
FunctionmRNA degradation, non-coding RNA processing

Table 2: Biological Roles of PARN

RoleDescription
mRNA DegradationShortens poly(A) tails to regulate mRNA stability
Non-coding RNA ProcessingInvolved in telomerase RNA and rRNA maturation
HematopoiesisEssential for differentiation of hematopoietic stem cells
Ribosome BiogenesisParticipates in 18S rRNA maturation

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference in order notes for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please consult your local distributor for precise delivery estimates.
Note: All proteins are shipped with standard blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to settle the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50% and can serve as a guideline.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot to prevent repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing.
The tag type is determined during production. If you require a specific tag, please inform us for preferential development.
Synonyms
parn; zgc:56067; Poly(A)-specific ribonuclease PARN; EC 3.1.13.4; Polyadenylate-specific ribonuclease
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Protein Length
Partial
Purity
>85% (SDS-PAGE)
Species
Danio rerio (Zebrafish) (Brachydanio rerio)
Target Names
parn
Uniprot No.

Target Background

Function
This 3'-exoribonuclease exhibits a preference for mRNA poly(A) tails, efficiently degrading them. Poly(A) tail exonucleolytic degradation is frequently the initial step in eukaryotic mRNA decay and also plays a role in silencing specific maternal mRNAs translationally during oocyte maturation and early embryonic development.
Database Links
Protein Families
CAF1 family
Subcellular Location
Cytoplasm. Nucleus.

Q&A

What is the function of PARN in zebrafish development?

PARN is a 3'-5' exoribonuclease that specifically degrades poly(A) tails of mRNAs, serving as a key regulator of mRNA stability and gene expression in zebrafish. During early embryogenesis, PARN plays a crucial role in the maternal-to-zygotic transition by facilitating the degradation of maternal transcripts, which is essential for proper developmental progression. PARN activity is particularly important during the first 24 hours post-fertilization, coinciding with the clearance of maternal mRNAs to allow zygotic gene expression to take over. The enzyme's deadenylation activity provides temporal control of protein synthesis by affecting mRNA stability and translation efficiency .

What experimental parameters affect PARN activity in vitro?

Several critical parameters significantly impact recombinant zebrafish PARN activity in vitro:

ParameterOptimal ConditionEffect on Activity
pH7.0-7.5Activity decreases dramatically below pH 6.5 or above pH 8.0
Divalent cations1.5-2.0 mM Mg²⁺Essential for catalysis; Mn²⁺ can substitute but alters specificity
Monovalent ions50-100 mM KClHigher concentrations (>150 mM) inhibit activity
Temperature25-28°CReflects physiological temperature in zebrafish
Substrate5'-capped poly(A) RNACap interaction enhances processivity
Reducing agents1-5 mM DTT or βMEMaintains enzyme stability and activity

The adenosine specificity in the active site is particularly affected by the choice of divalent metal ion, with Mg²⁺ promoting adenosine specificity while Mn²⁺ broadens substrate tolerance .

How do the substrate specificity mechanisms of zebrafish PARN differ from those observed in human PARN?

The RRM domain in zebrafish PARN contributes significantly to poly(A) binding, with mutations in this domain reducing poly(A) affinity while preserving catalytic function. This suggests a mechanistic separation between substrate binding and catalysis that may be differentially regulated in zebrafish compared to mammals .

What roles does PARN play in miRNA-mediated gene regulation during zebrafish development?

PARN functions as an integral component of miRNA-mediated gene silencing pathways in zebrafish development through several mechanisms:

  • PARN interacts with components of the miRNA-induced silencing complex (miRISC), including Argonaute proteins, facilitating targeted deadenylation of miRNA-bound transcripts.

  • During maternal-to-zygotic transition, PARN cooperates with the miR-430 family, which targets hundreds of maternal mRNAs for deadenylation and subsequent degradation.

  • PARN exhibits a sequential coordination with the CCR4-NOT complex, where PARN initiates poly(A) tail shortening followed by CCR4-NOT completing the deadenylation process.

  • RNA-immunoprecipitation studies reveal tissue-specific PARN-miRNA target sets, particularly enriched in neural tissues and developing gonads.

This integration of PARN activity with miRNA pathways creates a sophisticated regulatory network essential for proper developmental timing and tissue specification in zebrafish .

How can researchers distinguish between direct and indirect effects when studying PARN function in zebrafish models?

Distinguishing direct from indirect effects of PARN activity requires a multi-faceted approach:

  • Direct target identification: Employ CLIP-seq (Cross-linking immunoprecipitation sequencing) to identify RNA molecules directly bound by PARN in vivo. This approach captures physical interactions between PARN and its target RNAs.

  • Temporal analysis: Implement time-course experiments after PARN inhibition or knockout. Direct targets typically show immediate changes in poly(A) tail length (detectable within 2-6 hours), while secondary effects emerge later.

  • Poly(A) tail measurements: Use TAIL-seq or PAL-seq methodologies to directly measure poly(A) tail lengths transcriptome-wide. Direct PARN targets will show increased poly(A) tail lengths shortly after PARN depletion.

  • Substrate validation: Perform in vitro deadenylation assays with purified recombinant PARN and candidate target RNAs to confirm direct enzymatic activity.

  • Reporter assays: Construct reporter genes containing 3'UTRs from potential target mRNAs and assess their stability and translation efficiency in PARN-deficient versus wild-type backgrounds.

This integrated approach allows researchers to build a high-confidence set of direct PARN targets distinct from downstream regulatory effects .

What are the most effective approaches for generating zebrafish PARN loss-of-function models?

Researchers have several complementary options for creating PARN loss-of-function models in zebrafish:

  • CRISPR/Cas9 gene editing:

    • Design guide RNAs targeting conserved exons encoding the catalytic domain

    • Microinject 25-50 pg Cas9 mRNA with 25 pg guide RNA into one-cell embryos

    • Screen F0 founders for germline transmission of mutations

    • Establish stable mutant lines through outcrossing and genotyping

  • Morpholino-mediated knockdown:

    • Design translation-blocking morpholinos targeting the 5'UTR/start codon region

    • Optimize injection concentration (typically 0.1-0.3 mM)

    • Include appropriate controls (mismatch morpholinos, rescue experiments)

    • Validate knockdown efficiency by Western blot

  • Dominant-negative approach:

    • Express catalytically inactive PARN variants (e.g., with mutations in the active site)

    • Use tissue-specific or inducible promoters for temporal control

    • Monitor competition with endogenous PARN for substrate binding

  • Small molecule inhibition:

    • Treat embryos with deadenylation inhibitors at defined developmental stages

    • Titrate concentrations to minimize off-target effects

    • Validate specificity through rescue experiments

Each approach has distinct advantages for addressing different research questions, with CRISPR/Cas9 providing the most specific genetic model for long-term studies, while morpholinos offer rapid assessment of early developmental functions .

What is the optimal protocol for expressing and purifying recombinant zebrafish PARN protein?

For high-quality recombinant zebrafish PARN preparation:

  • Expression system selection: The yeast Pichia pastoris system provides an excellent balance of proper folding, post-translational modifications, and yield for zebrafish PARN expression .

  • Expression construct design:

    • Clone full-length zebrafish parn cDNA into pPICZα vector

    • Include N-terminal 6×His tag followed by a TEV protease cleavage site

    • Optimize codon usage for expression host

    • Verify sequence integrity before transformation

  • Expression conditions:

    • Transform P. pastoris strain X-33 or SMD1168

    • Induce expression with 0.5% methanol at 25°C for 48-72 hours

    • Monitor expression by small-scale time-course analysis

  • Purification workflow:

    • Harvest cells and disrupt using glass beads or mechanical homogenization

    • Prepare cleared lysate in buffer containing 50 mM Tris-HCl pH 7.5, 300 mM NaCl, 10% glycerol, and 5 mM β-mercaptoethanol

    • Perform initial capture on Ni-NTA resin

    • Apply TEV protease to remove His-tag

    • Perform ion exchange chromatography (MonoQ)

    • Complete purification with size exclusion chromatography

    • Concentrate to 1-2 mg/ml and store at -80°C in small aliquots

  • Quality control:

    • Assess purity by SDS-PAGE (>95%)

    • Verify oligomeric state by size exclusion chromatography

    • Confirm identity by mass spectrometry

    • Validate activity using standardized poly(A) degradation assays

This protocol yields enzymatically active zebrafish PARN suitable for biochemical and structural studies .

How should researchers design deadenylation assays to accurately measure zebrafish PARN activity?

Precise measurement of zebrafish PARN deadenylation activity requires careful assay design:

  • Substrate preparation:

    • Synthesize defined-length poly(A) RNA substrates (25-200 adenosines)

    • Include 5' cap structure (m7GpppG) for physiological relevance

    • Incorporate fluorescent (5'-Cy5) or radioactive labels for detection

    • Purify substrates to homogeneity by gel electrophoresis

  • Reaction conditions:

    • Buffer: 20 mM Tris-HCl pH 7.5, 50 mM KCl, 1.5 mM MgCl₂, 1 mM DTT

    • Enzyme concentration: 5-50 nM (titrate to ensure first-order kinetics)

    • Substrate concentration: 50-100 nM (below Km for initial rate determination)

    • Temperature: 25°C (zebrafish physiological temperature)

    • Time points: 0, 5, 10, 20, 30, 60 minutes

  • Analysis methods:

    • Denaturing PAGE for substrate length distribution

    • Phosphorimager or fluorescence scanning for quantification

    • Plot remaining substrate versus time for rate determination

    • Calculate processivity (adenosines removed per binding event)

  • Critical controls:

    • No-enzyme control

    • Heat-inactivated enzyme

    • EDTA-containing reaction (chelates metal ions)

    • Non-adenylated substrate to confirm specificity

  • Data analysis:

    • First-order rate constant determination

    • Comparative analysis across conditions

    • Michaelis-Menten parameters (Km, kcat, kcat/Km)

This methodology provides quantitative measurements of PARN activity suitable for comparing wild-type and mutant enzymes or assessing activity across developmental stages .

How can developmental stage-specific PARN functions be investigated in zebrafish?

To elucidate stage-specific PARN functions in zebrafish development:

  • Conditional knockdown/knockout strategies:

    • Heat-shock inducible CRISPR systems

    • Photoactivatable morpholinos

    • Chemical-inducible gene expression systems (e.g., Tet-On/Off)

    • Tissue-specific promoters driving Cre recombinase in floxed parn lines

  • Temporal expression profiling:

    • Quantitative RT-PCR of parn across developmental timepoints

    • In situ hybridization to map spatial expression patterns

    • Transgenic reporters (parn promoter driving fluorescent proteins)

    • Western blotting to track protein levels

  • Stage-specific rescue experiments:

    • Introduce wild-type PARN at defined developmental timepoints in mutant backgrounds

    • Use photoactivatable or caged mRNAs for temporal control

    • Assess phenotypic rescue to define critical periods for PARN function

  • Transcript-specific analyses:

    • Perform RNA-seq at multiple developmental stages in PARN-deficient embryos

    • Focus on maternal transcript clearance during early development

    • Analyze zygotic transcript stability during organogenesis

    • Examine tissue-specific effects during later development

  • Integrative analysis:

    • Correlate PARN expression/activity with target mRNA stability

    • Map developmental phenotypes to molecular changes

    • Create temporal activity maps across development

This multi-faceted approach reveals how PARN function transitions from maternal mRNA clearance to tissue-specific roles during later development .

What are the key considerations when analyzing phenotypes in zebrafish PARN mutants?

Comprehensive phenotypic analysis of zebrafish PARN mutants requires attention to several critical factors:

  • Developmental staging:

    • Use standardized staging criteria (hours post-fertilization, morphological landmarks)

    • Account for potential developmental delays when comparing to wild-type

    • Document development at multiple timepoints to capture progressive phenotypes

  • Genetic background considerations:

    • Maintain consistent genetic backgrounds when comparing mutants

    • Generate and analyze multiple independent mutant alleles

    • Create maternal-zygotic mutants to assess complete loss of function

  • Phenotypic characterization hierarchy:

    • Morphological assessment (body axis, organ formation, pigmentation)

    • Behavioral analysis (swimming patterns, responses to stimuli)

    • Cellular defects (using tissue-specific markers)

    • Molecular signatures (transcriptome, poly(A) tail dynamics)

  • Quantitative phenotyping approaches:

    • Develop objective scoring systems for morphological traits

    • Employ automated behavioral tracking systems

    • Use image analysis software for consistent measurement

    • Apply appropriate statistical methods for categorical and continuous data

  • Distinguishing primary from secondary effects:

    • Conduct time-course analyses to identify earliest defects

    • Perform tissue-specific rescue experiments

    • Use transcriptomics to identify direct PARN targets

    • Compare with phenotypes of other deadenylase mutants

This framework enables comprehensive characterization of how PARN dysfunction affects zebrafish development at organismal, cellular, and molecular levels .

How does maternal versus zygotic PARN contribution affect experimental interpretations in zebrafish?

Understanding the distinct contributions of maternal and zygotic PARN is crucial for accurate experimental interpretation:

  • Distinguishing maternal from zygotic effects:

    • Generate maternal-zygotic mutants (MZ, from homozygous mutant females)

    • Compare with zygotic-only mutants (Z, from heterozygous females)

    • The difference between MZ and Z phenotypes represents the maternal contribution

  • Developmental implications:

    • Maternal PARN primarily affects early development (first 6-10 hours)

    • Zygotic PARN becomes critical during and after maternal-to-zygotic transition

    • Some phenotypes may only appear in maternal-zygotic mutants

  • Experimental design adaptations:

    • Use maternal-specific knockdown techniques for early effects

    • Employ heat-shock inducible systems to bypass early requirements

    • Perform tissue-specific manipulations to isolate later functions

  • Molecular profiling strategies:

    • Analyze poly(A) tail lengths of known maternal transcripts

    • Perform ribosome profiling to assess translation regulation

    • Compare transcriptomes between MZ and Z mutants at multiple stages

  • Rescue experiment design:

    • Inject wild-type parn mRNA at the one-cell stage to rescue maternal contribution

    • Use transgenic expression to rescue zygotic functions

    • Apply tissue-specific rescue to map requirement domains

This approach creates a comprehensive understanding of PARN function throughout development and prevents misattribution of phenotypes to the wrong developmental program .

What high-throughput approaches can identify the complete repertoire of PARN targets in zebrafish?

Comprehensive identification of PARN targets in zebrafish requires integration of multiple high-throughput methodologies:

  • CLIP-seq (Cross-linking immunoprecipitation sequencing):

    • UV-crosslink PARN to its RNA targets in vivo

    • Immunoprecipitate PARN-RNA complexes

    • Sequence captured RNA fragments

    • Identify direct binding sites with nucleotide resolution

  • TAIL-seq (Poly(A) tail sequencing):

    • Compare wild-type and PARN-deficient samples

    • Measure poly(A) tail lengths transcriptome-wide

    • Identify mRNAs with extended poly(A) tails in PARN mutants

    • Correlate with expression changes

  • Ribosome profiling:

    • Assess translational efficiency changes upon PARN manipulation

    • Correlate with poly(A) tail length alterations

    • Identify functional consequences of PARN-mediated deadenylation

  • Degradome sequencing:

    • Capture and sequence RNA decay intermediates

    • Identify transcripts undergoing active degradation

    • Compare degradation patterns between wild-type and PARN mutants

  • Data integration framework:

    • Develop computational pipelines to integrate multiple data types

    • Apply machine learning to predict high-confidence PARN targets

    • Validate top candidates with reporter assays

    • Categorize targets by developmental stage and tissue specificity

This multi-omics approach creates a comprehensive map of PARN targets and their regulatory dynamics throughout zebrafish development .

How can researchers accurately quantify PARN enzymatic parameters in zebrafish developmental contexts?

For precise quantification of PARN enzymatic parameters in developmental contexts:

  • Developmental stage-specific extract preparation:

    • Collect synchronously developing embryos at defined stages

    • Generate cytoplasmic extracts under native conditions

    • Normalize protein concentration across samples

    • Verify PARN levels by immunoblotting

  • Activity measurement approaches:

    • In-extract deadenylation assays using defined substrates

    • Immunodepletion controls to confirm PARN-specific activity

    • Comparison with recombinant enzyme under matched conditions

    • Inclusion of physiological competitors and regulators

  • Kinetic parameter determination:

    • Measure initial rates across substrate concentrations

    • Determine apparent Km and Vmax at each developmental stage

    • Assess processivity through single-molecule approaches

    • Quantify cap-dependence through comparative kinetics

  • Physiological substrate testing:

    • Isolate native mRNPs from staged embryos

    • Measure deadenylation rates on these physiological substrates

    • Compare with synthetic substrate behavior

    • Assess influence of associated proteins

  • Quantitative analysis framework:

    • Apply appropriate enzyme kinetic models

    • Account for competing activities in extracts

    • Normalize for PARN concentration differences

    • Create developmental enzyme activity profiles

This methodology reveals how PARN kinetic parameters evolve through development and respond to changing cellular environments .

What approaches can resolve contradictions between in vitro and in vivo PARN activity data?

When confronting discrepancies between in vitro and in vivo PARN activity:

  • Identify potential sources of discrepancy:

    • Missing cofactors or regulators in vitro

    • Compartmentalization effects in vivo

    • Post-translational modifications

    • Competing or cooperative factors in cells

    • Substrate accessibility differences

  • Bridging experimental approaches:

    • Supplement in vitro reactions with cellular fractions

    • Perform activity assays in semi-permeabilized cells

    • Immunoprecipitate native PARN complexes for activity testing

    • Compare recombinant and endogenous PARN directly

  • Systematic variant testing:

    • Test PARN variants lacking specific domains

    • Create phosphomimetic mutations to simulate PTMs

    • Assess activity with and without potential regulators

    • Vary reaction conditions to better match cellular environment

  • Advanced imaging approaches:

    • Develop FRET-based PARN activity reporters

    • Visualize deadenylation in living cells

    • Track substrate and enzyme dynamics simultaneously

    • Correlate spatial organization with activity

  • Mathematical modeling:

    • Develop kinetic models incorporating cellular factors

    • Fit experimental data from both in vitro and in vivo sources

    • Identify parameters that explain discrepancies

    • Use models to predict conditions that reconcile differences

This systematic approach identifies the cellular factors and conditions that modify PARN activity in vivo, explaining apparent contradictions and providing a more complete understanding of physiological regulation .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.